Impact of oxygen-ozone mixture on cellular functions: a biochemical perspective across cell types
Khalid A., Sala A., Forlino A., Besio R.
Narrative Review, published in Mol Med (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Mol Med (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41987079
- PMCID
- PMC13214387
- DOI
- 10.1186/s10020-026-01475-8
- Citations
- 1
Abstract (original English)
Adaptive responses induced by low-dose stressors can enhance cellular resilience and system functionality. In this context, ozone, a potent oxidant known for its UV-shielding and antimicrobial properties, has attracted interest over the past decades for its potential therapeutic applications, when administered as a controlled mixture of 1–5% ozone and 95–99% oxygen. Emerging evidence supports the action of this mixture in stimulating the endogenous stress response through induction of moderate oxidative stress, ultimately yielding beneficial effects. The exposure to the mixture contributes to cell homeostasis restoration by activating key biochemical pathways involved in antioxidant defence, and in regulation of inflammation and immune responses, depending on the physiological/pathological condition and the specific cellular context. This review discusses oxygen–ozone mixture molecular mechanisms and its pivotal cellular targets, focusing on cell types for which robust evidence is available from preclinical studies. Comparative analyses of in vitro and in vivo literature data revealed that the oxygen–ozone mixture activates common molecular pathways across different cell types; however, downstream cellular responses diverge substantially, manifesting as adaptive, protective, or regenerative effects and underscoring the need for context-specific therapeutic applications. The ozo
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.